Woburn, Massachusetts (MA) Biological Products, Except Diagnostic Substances Companies

Featured companies
Mercury Therapeutics Inc
2 Gill St.
Woburn MA 01801
(781) 932-1125
Immuno Diagnostics Inc
21f Olympia Ave.
Woburn MA 01801
(781) 938-6300
Newton Laboratories Inc
23 Cummings Park
Woburn MA 01801
(781) 933-2111
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Select Therapeutics Inc
52 Cummings Park # B
Woburn MA 01801
(781) 939-5650
Aphios Corp
3 Gill St # E
Woburn MA 01801
(781) 932-6933
Aarvon Biosciences Inc
400 Tradecenter # 5900
Woburn MA 01801
(781) 569-5850
Asia Culture Center
368 West Cummings Park
Woburn MA 01801
(781) 933-8088

Asia culture center for u.s
Amgen Inc
34 Commerce Way
Woburn MA 01801
(781) 376-4900
Excelimmune Inc
12b Cabot Road
Woburn MA 01801
(781) 569-0601
Novatein Biosciencs Corp
310 West Cummings Park
Woburn MA 01801
(617) 238-1396
Pierce Biotechnology
35 Cabot Road
Woburn MA 01801
(781) 938-1338
Whereorg has 21 results under Biological Products, Except Diagnostic Substances Companies in Woburn, MA.

Narrow down the browsing criteria below to see more companies.

Select a category for location Middlesex, Massachusetts

Other locations for category Biological Products, Except Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020